Abstract:Introduction Renal artery stenosis (RAS) is one aspect of a multiterritory atherosclerotic disease. This study was to evaluate the incidence of RAS in the patients with CHD treating with various therapeutic regimen. Method From July 2008 to March 2010, intra-renal arterial digital subtraction angiography was performed in 302 patients who underwent coronary angiography. The incidence of ≥50% unilateral or bilateral renal artery stenosis were investigated in the population of the patients without and with CHD treating with various therapeutic regimens as following. By evaluating the coronary angiogram, the patients were not diagnosed to have CHD with less than 50% diameter stenosis of coronary artery; CHD was defined as narrowing of the appropriate lumen of ≥50%; the procedure of PCI were performed in the patients with more than or equal to 70% stenosis; the CABG had been proposed in patients with left main coronary artery lesions, left main equivalent, diffuse triple coronary artery lesions, two-vessel disease with significant proximal left anterior descending CAD. the intra-renal arterial digital subtraction angiography was performed, the renal artery stenosis was evaluated by three interventional cardiologists. RAS was defined as narrowing of the appropriate lumen of ≥50%. Results In 302 patients, 47 patients (15.56%) had not been diagnosed to have CHD; 255 (84.44%) to have CHD, of these patients with CHD, 80 patients (26.49%) were not indicated for PCI, 24 (7.95%) had been performed the procedure of stent implantation, 151(50%) proposed to have CABG. The incidence rates of renal artery stenosis were 6.38% (3/47) in patients without CHD and 40% (102/302) in patients with CHD (p=0.00087). In the four various therapeutic regimen groups, the incidence rates of RAS were 6.38% (3/47) in the patients without CHD, 35% (28/80) in the patients who were not indicated for PCI, 12.5% (3/24) in the patients performed stent implantation, and 47.02% (71/151) in the patients proposed to CABG. the incidence of RAS of the patients performed stent implantation was significantly lower than the patients who were not indicated for PCI (p=0.035) and the patients proposed to CABG (p=0.001). The age of was significantly older in patients with RAS than without RAS (p Conclusion The incidence of RAS was 6.38%% in patients without CHD and 40% in patients with CHD. The incidence of RAS of the patients who were not indicated for PCI or proposed to CABG was higher than the patients performed stent implantation and patients without CHD. the age, Diabetes, Cerebral infarction, CHD, Grade 3 hypertension, and very high risk factors for cardiovascular diseases are the risk factors for RAS.

Clinical Value of Renin-angiotensin System Evaluation in Percutaneous Transluminal Renal Angioplasty

Analyse of intervention therapy in renal artery stenosis

Endovascular revascularization for the treatment of renal artery stenosis

Study of the Correlation between Renin and the Prognosis of Atherosclerotic Renal Artery Stenting

Long term outcome of PTRA and stenting in patients with atherosclerotic renal artery stenosis and predictors analysis

BLOOD PRESSURE AND RENAL FUNCTION CHANGES AFTER REVASCULARIZATION OF RENAL ARTERY STENOSIS IN 3 DIFFERENT COHORTS OF PATIENTS

Diabetes Insipidus-Like State Complicating Percutaneous Transluminal Renal Stenting for Transplant Renal Artery Stenosis.

Renal Dynamic Imaging for the Treatment Assessment of Renal Artery Angioplasty and Stenting in Patients with Atherosclerotic Renal Artery Stenosis

Efficacy of Percutaneous Transluminal Renal Angioplasty for Pediatric Renovascular Hypertension: a Meta-Analysis

The Impact of Renal Artery Stent Revascularization on Blood Pressure: 1-Year Follow-Up of 110 Cases

Long-term clinical effectiveness of renal artery intervention in patients with renal artery stenosis

The Efficacy of Endovascular Interventional in Severe Stenosis of Bilateral Renal Stenosis

Midterm Outcomes of Angioplasty for Pediatric Renovascular Hypertension

Clinical efficacy of stent revascularization in treatment of atherosclerotic renal artery stenosis

THE INCIDENCE OF RENAL ARTERY STENOSIS IN THE PATIENTS WITH CHD TREATING WITH VARIOUS THERAPEUTIC REGIMENS

Outcomes of percutaneous transluminal renal angioplasty for pediatric renovascular hypertension: a 12-year retrospective single-center experience

Treatment progress of ischemic renal disease

Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis

The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysis

Renal perfusion improvement in the perioperative period after unilateral endovascular revascularization in patients with atherosclerotic renal artery stenosis

Contrast-enhanced ultrasound evaluation of renal blood perfusion changes after percutaneous transluminal renal angioplasty and stenting for severe atherosclerotic renal artery stenosis